Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hepatitis

  Free Subscription


20.07.2026

1 BMC Cancer
3 Clin Infect Dis
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Gut
2 Hepatology
4 J Viral Hepat
1 J Virol
1 Pediatr Infect Dis J
3 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. PENG J, Lin Q, Zhou Z, Wen Q, et al
    Potentially functional variants of CYP2A6 and ABHD12 in the arachidonic acid metabolism pathway genes predict the survival of HBV-related hepatocellular carcinoma patients.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16212.
    PubMed         Abstract available


    Clin Infect Dis

  2. MARTIN NK, Chaillon A, Vickerman P, MacGregor L, et al
    Optimizing HCV Screening to Maximize Health Benefit Among Men Who Have Sex with Men in the United States: A Cost-Effectiveness Analysis.
    Clin Infect Dis. 2026 Jul 15:ciag416. doi: 10.1093.
    PubMed         Abstract available

  3. TALAL AH
    Toward Optimal Hepatitis C Virus Screening Approaches among Men Who Have Sex with Men.
    Clin Infect Dis. 2026 Jul 15:ciag417. doi: 10.1093.
    PubMed        

  4. HUANG YS, Sun HY, Lin KY, Huang SH, et al
    Birth in the neonatal HBV vaccination era and hepatitis B surface antigen seroclearance in people with HIV and HBV coinfection on tenofovir-containing antiretroviral therapy.
    Clin Infect Dis. 2026 Jul 11:ciag429. doi: 10.1093.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  5. TOZLUKLU NN, Karaogullarindan U
    Hepatocellular carcinoma development after hepatitis B surface antigen seroclearance in chronic hepatitis B patients: a 10-year single-center cohort study.
    Eur J Gastroenterol Hepatol. 2026 Jun 16. doi: 10.1097/MEG.0000000000003233.
    PubMed         Abstract available


    Gastroenterology

  6. EL-DEBEIKY S, Hiu-Fung Lam T, Sze-Man Lai M, Tse YK, et al
    Long-term incidence of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
    Gastroenterology. 2026 Jul 13:S0016-5085(26)07043.
    PubMed         Abstract available


    Gut

  7. MAO T, Wu Y, Gu Z, Abulaiti A, et al
    DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?
    Gut. 2026 Jul 15:gutjnl-2026-339913. doi: 10.1136/gutjnl-2026-339913.
    PubMed        


    Hepatology

  8. LEI Z, Wu Y, Xue W, Zhu D, et al
    Epigenetic repression of hepatocyte FoxO1 disrupts local immune homeostasis and promotes liver inflammation.
    Hepatology. 2025 Nov 4. doi: 10.1097/HEP.0000000000001590.
    PubMed         Abstract available

  9. FELD JJ, Gehring AJ, Zoulim F
    Getting to HBV cure-Will new biomarkers help?
    Hepatology. 2026;84:582-600.
    PubMed         Abstract available


    J Viral Hepat

  10. ETOORI D, Simmons R, Powell A, Desai M, et al
    Trends in Mortality After the Roll-Out of Directly Acting Antivirals for Hepatitis C in England Using Linked Surveillance Data.
    J Viral Hepat. 2026;33:e70210.
    PubMed         Abstract available

  11. HUI RW, Wong DK, Fung J, Cheung KS, et al
    Droplet Digital PCR Measurement of HBV DNA in On-Treatment Chronic HBV Patients: Association With HCC Development and Outcomes.
    J Viral Hepat. 2026;33:e70209.
    PubMed         Abstract available

  12. VAN STRATEN CGJI, van Benthem BHB, van der Klis FRM, Smits G, et al
    Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys.
    J Viral Hepat. 2026;33:e70213.
    PubMed         Abstract available

  13. SUOH M, Esmaili S, Eslam M, George J, et al
    Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.
    J Viral Hepat. 2026;33:e70206.
    PubMed         Abstract available


    J Virol

  14. CHAZOVA O, Zaiets I, Gudima SO
    Drug resistance mutations of hepatitis B virus (HBV) influence the yield of the virions of the human hepatitis delta virus (HDV) and their infectivity.
    J Virol. 2026 Jul 13:e0061026. doi: 10.1128/jvi.00610.
    PubMed         Abstract available


    Pediatr Infect Dis J

  15. MADAENG T, Soponkanaporn S, Tangnararatchakit K, Apiwattanakul N, et al
    Immunogenicity of Hepatitis B Vaccine in Pediatric Systemic Lupus Erythematosus Patients: ERRATUM.
    Pediatr Infect Dis J. 2026 Jul 17. doi: 10.1097/INF.0000000000005322.
    PubMed        


    PLoS One

  16. INOUE CA, Domingues TSP, Sucupira MCA, Sitnik R, et al
    The epidemiology of the viral hepatitis in Brazil: A scoping review.
    PLoS One. 2026;21:e0353840.
    PubMed         Abstract available


  17. Correction: Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression.
    PLoS One. 2026;21:e0354253.
    PubMed         Abstract available

  18. STUART A, Horst C, Mullen D, Lowndes C, et al
    Barriers and facilitators to hepatitis C patient engagement: Interview study with general practitioner champions in England.
    PLoS One. 2026;21:e0337867.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum